Eton Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Eton Pharmaceuticals, Inc. (ETON) had Shares Outstanding (Cover Page) of 28.58 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 28.58M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 27.39M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 27.28M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 26.82M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 28.58M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 27.39M shares 10-Q · filed 2026-05-14 |
| 2026-03-17 | 27.28M shares 10-K · filed 2026-03-19 |
| 2025-11-05 | 26.82M shares 10-Q · filed 2025-11-06 |
| 2025-08-05 | 26.82M shares 10-Q · filed 2025-08-07 |
| 2025-05-09 | 26.82M shares 10-Q · filed 2025-05-13 |
| 2025-03-10 | 26.82M shares 10-K · filed 2025-03-18 |
| 2024-10-31 | 25.84M shares 10-Q · filed 2024-11-12 |
| 2024-08-01 | 25.84M shares 10-Q · filed 2024-08-08 |
| 2024-05-02 | 25.69M shares 10-Q · filed 2024-05-09 |
| 2024-03-21 | 25.69M shares 10-K/A · filed 2024-03-22 |
| 2024-03-05 | 25.69M shares 10-K · filed 2024-03-14 |
| 2023-11-03 | 25.66M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 25.65M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 25.50M shares 10-Q · filed 2023-05-11 |
| 2023-03-07 | 25.46M shares 10-K · filed 2023-03-16 |
| 2022-10-31 | 25.30M shares 10-Q · filed 2022-11-10 |
| 2022-07-31 | 25.30M shares 10-Q · filed 2022-08-11 |
| 2022-04-30 | 25.22M shares 10-Q · filed 2022-05-12 |
| 2022-03-07 | 24.63M shares 10-K · filed 2022-03-16 |
| 2021-11-10 | 24.61M shares 10-Q · filed 2021-11-16 |
| 2021-08-09 | 24.60M shares 10-Q · filed 2021-08-16 |
| 2021-04-30 | 24.51M shares 10-Q · filed 2021-05-13 |
| 2021-03-08 | 24.41M shares 10-K · filed 2021-03-16 |
| 2020-11-02 | 24.21M shares 10-Q · filed 2020-11-12 |
| 2020-07-31 | 20.96M shares 10-Q · filed 2020-08-12 |
| 2020-04-30 | 20.92M shares 10-Q · filed 2020-05-14 |
| 2020-02-28 | 17.88M shares 10-K · filed 2020-03-05 |
| 2019-10-31 | 17.81M shares 10-Q · filed 2019-11-14 |
| 2019-07-31 | 17.76M shares 10-Q · filed 2019-08-06 |
| 2019-04-30 | 17.63M shares 10-Q · filed 2019-05-07 |
| 2019-03-15 | 17.63M shares 10-K · filed 2019-03-25 |
| 2018-12-14 | 17.61M shares 10-Q · filed 2018-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |